Model
Edge
Tonix Pharmaceuticals Holding Corp
TNXP
Filing Type
10-Q
Filing Date
5/12/2024
Updated
5/13/24, 2:51 PM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q1
EX-31.01
CHIEF EXECUTIVE OFFICER'S CERTIFICATE PURSUANT TO SECTION 302
EX-31.02
CHIEF FINANCIAL OFFICER'S CERTIFICATE PURSUANT TO SECTION 302
EX-32.01
CHIEF EXECUTIVE OFFICER'S AND CHIEF EXECUTIVE OFFICER'S CERTIFICATE PURSUANT TO SECTION 906